Andra Krauze - Concepedia

Author

Andra Krauze

National Cancer Institute ORCID

Also Known As

A. Krauze, A.V. Krauze, Andra Krauze, Andra V Krauze, Andra V. Krauze, Andra Valentina Krauze, Krauze, Andra V.

140

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research University of British Columbia Virginia Commonwealth University

About

Andra Krauze is an author at National Cancer Institute specializing in medicine, radiation oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	432
2	Health Sciences	3	3	92
3	Engineering	2	2	68
4	Biostatistics	2	2	68
5	Data Science	2	2	68

Andra Krauze

Publications

Citations

H-Index

Page 1

	Year	Citations
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma Andra Krauze, Sten Myrehaug, Michael G. Chang, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyOncologyRadiation TherapyMedicineAnti-cancer Agent	2015	199
Automated glioma grading on conventional MRI images using deep convolutional neural networks Ying Zhuge, Holly Ning, Peter Mathen, Medical Physics	2020	161
A Prospective Study on <sup>18</sup>F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer Étienne Rousseau, Don Wilson, F. Lacroix-Poisson, Journal of Nuclear Medicine	2019	108
Brain tumor segmentation using holistically nested neural networks in MRI images Ying Zhuge, Andra Krauze, Holly Ning, Medical Physics	2017	104
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study H. Ian Robins, Peixin Zhang, Mark R. Gilbert, Journal of Neuro-Oncology Neuro-oncologyGliomaMedicinePharmacologyAnti-cancer Agent	2015	73
Hierarchical Voting-Based Feature Selection and Ensemble Learning Model Scheme for Glioma Grading with Clinical and Molecular Characteristics Ying Zhuge, Harpreet Kaur, Kevin Camphausen, International Journal of Molecular Sciences EngineeringMachine LearningMolecular MarkersFeature SelectionGlioma	2022	52
Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM Lindsay Rowe, John A. Butman, Megan Mackey, Journal of Neuro-Oncology Translational MedicineDisease ProgressionDifferential DiagnosisClinical CluesDiagnosis	2018	41
Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial François Bénard, Sara Harsini, Don Wilson, The Lancet Oncology Positron Emission TomographyBone ImagingHealth SciencesOncologic ImagingMedicine	2022	39
Expert consensus on re-irradiation for recurrent glioma Andra Krauze, Albert Attia, Steve Braunstein, Radiation Oncology	2017	38
Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy Luca Valle, Matthew D. Greer, Joanna H. Shih, Diagnostic and Interventional Radiology	2018	33

Page 1